Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...] Read More »
Articles by : Shannon Young, Associate Editor/Senior Writer
A subcommittee of the House Energy and Commerce (E&C) Committee, which is tasked with overseeing the 340B drug discount program, [...] Read More »
The Rhode Island Senate yesterday approved legislation that would prohibit 340B contract pharmacy restrictions in that state, sending it to [...] Read More »
Ohio Community Health Center CEOs, Lawmakers Urge Passage of State Contract Pharmacy Protection Bill
Ohio federally qualified health center (FQHC) leaders called on state lawmakers Tuesday to pass newly introduced legislation that would end [...] Read More »
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...] Read More »
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...] Read More »
Ohio is the latest state to consider proposed legislation that would ban drugmakers from restricting covered entities’ acquisition of 340B [...] Read More »
A Kansas law that prohibits drugmaker 340B contract pharmacy restrictions is set to take effect July 1, as result of [...] Read More »
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] Read More »
North Carolina hospitals that participate in the 340B program routinely overcharged cancer patients, taxpayers and state employees for oncology drugs, [...] Read More »